NEW YORK, Nov 8 - Lion Bioscience on Wednesday reported a 136 percent increase in revenues in the second quarter of fiscal 2001 to 4.5 million euros ($3.84 million), compared with 1.9 million euros in the year ago period.

The company said that revenues for the first half of the year were up 177 percent to 7.8 million euros from 2.2 million euros a year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.